Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-01 · accession 0001415889-24-028071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-03 | 2024-12-01 | STOK | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +33.9K | 38.8K | +691% | $0 |
| D | 2024-12-03 | 2024-12-01 | STOK | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | -33.9K | 12.4K | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-01 | M | A | 33,927 | $0.00 | 38,838 | D | — | — | (F1) The reported total includes an aggregate 2,313 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d). |
| 2 | Derivative | Restricted Stock Unit (RSU) | 2024-12-01 | M | D | 33,927 | $0.00 | 12,357 | D | — · — to 2025-12-01 | 33,927 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. (F3) 33,927 restricted stock units vest on December 1, 2024 and 12,357 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date. |